Publications by authors named "G Mavria"

Claim this Profile
D
Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies.
Claire E L Smith, Andrew J Streets, Alice V R Lake, Subaashini Natarajan, Sunayna K Best, Georgia Mavria

Commun Med (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activity.
Vinton W T Cheng, Philippa Vaughn-Beaucaire, Gary C Shaw, Malte Kriegs, Alastair Droop, Georgia Mavria

Cell Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling.
Chiara Galloni, Teklu Egnuni, Safoura Zahed Mohajerani, Jiaqi Ye, Sibylle Mittnacht, Georgia Mavria

Commun Biol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour associated vasculature-on-a-chip for the evaluation of microbubble-mediated delivery of targeted liposomes.
Matthew D Bourn, Safoura Zahed Mohajerani, Georgia Mavria, Nicola Ingram, P Louise Coletta

Lab Chip· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. 2021, , 5939.
Anke Brüning-Richardson, Gary C Shaw, Daniel Tams, Tim Brend, Hitesh Sanganee, Georgia Mavria

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis